Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study

NCT02414438 is registered in ClinicalTrials.gov with Qure Healthcare, LLC as lead sponsor.

NCT NCT02414438
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02414438 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Establishing the Clinical Utility of First StepDx PLUS and NextStepDx PLUS Study
Lead sponsor
Qure Healthcare, LLC
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2014
Completion date
January 31, 2015
Enrollment
217 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

developmental delay, intellectual disability